Clusterin regulates microglial inflammation and cognitive function independent of amyloid pathology in Alzheimer's disease
Rawal, P.; Moon, H.-J.; Nguyen, V.; Khatri, S.; Larson, M. A.; Vivian, J. C.; Saido, T. C.; Zhao, L.
Show abstract
Clusterin (CLU) is a major genetic risk factor for late-onset Alzheimers disease (AD), yet the mechanism underlying this risk remains unclear. This study investigated the role of CLU in regulating microglial inflammation, amyloid pathology, and cognitive function in CLU-deficient and AD models. CLU synthesis and secretion in microglia were highly dynamic, with minimal expression at rest but markedly increased expression upon pro-inflammatory stimulation. CLU deficiency amplified microglial activation and inflammatory responses, whereas introducing recombinant CLU protein reduced microglial inflammation. In a human mutant APP knock-in AD mouse model, loss of CLU impaired learning and memory despite a reduced amyloid burden. snRNA-seq analysis further revealed that CLU loss disrupted the balance between excitatory and inhibitory neurons. These findings provide novel insights indicating that CLU likely functions as a negative feedback regulator of microglial activation and inflammation, thereby promoting microglial resolution and neuronal homeostasis, and consequently, cognitive outcomes independent of amyloid pathology.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Microglial and Astrocyte priming in the APP/PS1 model of Alzheimer’s Disease: increased vulnerability to acute inflammation and cognitive deficits 95%
- TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease 95%
- Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer's Disease and Related Dementias. 95%
Similar papers in this journal
- GWAS on short tandem repeats identifies novel genetic mechanisms in Alzheimer's disease 96%
- Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy 95%
- TFEB degradation is regulated by an IKK/β-TrCP2 phosphorylation-ubiquitination cascade 95%
Similar papers in this journal
Similar papers in this journal
- Mutations in PSEN1 predispose inflammation in an astrocyte model of familial Alzheimer's disease through disrupted regulated intramembrane proteolysis 97%
- Tau Secretion and Propagation Is Regulated by p300/CBP via Autophagy-Lysosomal Pathway in Tauopathy 94%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.